EUVIMEDEUVIMED entdecken
Open Access

Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer

Yi-Wen Wang, Yih-Lin Tuan, Jiu-Yao Wang, Hong-Yi Chang, Chien-An Chu, Yi-Lin Chen, Hui-Wen Chen, Chung-Liang Ho, Chung-Ta Lee, Nan-Haw Chow

Oncology Reports · 2024

DOI: 10.3892/or.2024.8849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Yi-Wen Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Safety Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Proliferation, Erb-b2 Receptor Tyrosine Kinases, Xenograft Model Antitumor Assays. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCell ProliferationErb-b2 Receptor Tyrosine KinasesXenograft Model Antitumor AssaysMembrane GlycoproteinsHumansFemaleAnimalsMiceCell Line, TumorCell MovementTrastuzumabEpithelial-Mesenchymal TransitionReceptors, ProgesteroneGene Expression Regulation, NeoplasticMiddle AgedReceptors, EstrogenDrug Resistance, NeoplasmBiomarkers, TumorErbB ReceptorsMolecular Targeted TherapyAdultAged

Stichwörter der Autor:innen

EMP3HER familybreast carcinomaestrogen receptorprogesterone receptortherapy

Substanzen

Erb-b2 Receptor Tyrosine KinasesMembrane GlycoproteinsTrastuzumabReceptors, ProgesteroneReceptors, EstrogenBiomarkers, TumorErbB ReceptorsERBB2 protein, humanEMP3 protein, human

Autor:innen und Institutionen

  • Department of Food Safety Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C.
  • Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C.
  • Center for Allergy, Immunology, and Microbiome, China Medical University Hospital, China Medical University, Taichung 404327, Taiwan, R.O.C.
  • Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan, R.O.C.
  • Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C.
  • Department of Pathology, National Cheng Kung University Hospital, Tainan 701401, Taiwan, R.O.C.

Zitieren

APA

Wang, Y. W., Tuan, Y. L., Wang, J. Y., Chang, H. Y., Chu, C. A., Chen, Y. L., Chen, H. W., Ho, C. L., Lee, C. T., & Chow, N. H. (2024). Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer. Oncology Reports. https://doi.org/10.3892/or.2024.8849

Vancouver

Wang YW, Tuan YL, Wang JY, Chang HY, Chu CA, Chen YL, et al. Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer. Oncology Reports. 2024. doi:10.3892/or.2024.8849

BibTeX
@article{Wang2024,
  author = {Wang, Yi-Wen and Tuan, Yih-Lin and Wang, Jiu-Yao and Chang, Hong-Yi and Chu, Chien-An and Chen, Yi-Lin and Chen, Hui-Wen and Ho, Chung-Liang and Lee, Chung-Ta and Chow, Nan-Haw},
  title = {Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8849}
}
Kostenlos starten →